.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Fuji
Julphar
Accenture
Harvard Business School
US Department of Justice
Moodys
Medtronic
Citi

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: auranofin

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sebela Ireland Ltd
RIDAURA
auranofin
CAPSULE;ORAL018689NDASebela Pharmaceuticals Inc.54766-093-0660 CAPSULE in 1 BOTTLE (54766-093-06)
Sebela Ireland Ltd
RIDAURA
auranofin
CAPSULE;ORAL018689NDAPrometheus Laboratories Inc.65483-093-0660 CAPSULE in 1 BOTTLE (65483-093-06)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Johnson and Johnson
Medtronic
Fish and Richardson
Accenture
McKesson
Healthtrust
AstraZeneca
Colorcon

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot